The use of off-label multiplex molecular testing for UTIs in older adults has soared, with the biggest rise occurring in claims for nursing home residents.
Treating a kidney infection involves consulting with a doctor for antibiotics, staying hydrated, and managing pain.
Most of Dr. Leah Schrupp’s patients know it. So do most of Dr. Erin Knudtson’s patients. If they visit their doctor with a runny nose, chest cold or the usual flu symptoms, they ...
Researchers have found in a new study that fluoroquinolones (FQs), widely used for urinary tract infections (UTIs), are not ...
AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...
It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.
AbbVie received Food and Drug Administration approval of Emblaveo, an intravenous antibiotic, for treatment of adults with complicated intra-abdominal infections with limited or no treatment options.
Overall, 45.8% of COVID-19 hospital admissions and 51.2% of admissions for other respiratory viruses received at least one ...
The findings contradict a 2018 Food and Drug Administration warning that fluoroquinolone use could increase the risk of ...
New insights into what causes the painful and disruptive symptoms of urinary tract infections (UTIs) could offer hope for ...
New insights into what causes the painful and disruptive symptoms of urinary tract infections (UTIs) could offer hope for improved treatment.
New insights into what causes the painful and disruptive symptoms of urinary tract infections (UTIs) could offer hope for improved treatment. UTIs are one of the most prevalent bacterial infections ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback